Neck News and Research

RSS

Survey finds high levels of abuse, serious harm associated with human trafficking

The largest survey to date of the health of trafficking survivors has found high levels of abuse and serious harm associated with human trafficking. For the first time, the findings reveal severe mental and physical health problems experienced by men, women and children trafficked for forced labour and sexual exploitation in Southeast Asia.

18 Feb 2015

Researchers say that cancer experience can lead to healthy lifestyle in survivors and family members

After studying cancer survivors and their family caregivers, researchers at Case Western Reserve University conclude that the period between the final cancer treatment and first post-treatment checkup may be an ideal time for the entire household to jumpstart a healthy lifestyle.

18 Feb 2015

Cervarix effective against other common cancer-causing HPVs

According to a multinational clinical trial involving nearly 20,000 young women, the human papilloma virus vaccine, Cervarix, not only has the potential to prevent cervical cancer, but was effective against other common cancer-causing human papillomaviruses, aside from just the two HPV types, 16 and 18, which are responsible for about 70 percent of all cases.

15 Feb 2015

$Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC$

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

13 Feb 2015

Montefiore Einstein Center for Cancer Care receives CoC accreditation

Montefiore Einstein Center for Cancer Care, a premier cancer center that provides patient-centered care for prevention, diagnosis and treatment of cancer, today announced that it has received Three-Year Accreditation with Silver Level Commendation from the Commission on Cancer of the American College of Surgeons.

12 Feb 2015

Scientists find that collagen 'cross-links' can determine tumor's ability to grow and spread

When skyscrapers go up, contractors rely on an infrastructure of steel beams and braces. Some cancers grow the same way, using a biological matrix from which the tumor can thrive and spread.

10 Feb 2015

New model proposed for predicting outcomes more accurately in HPV-related throat cancer patients

Researchers at the Princess Margaret Cancer Centre are proposing a new model to enable doctors to predict outcomes more accurately for patients with throat cancers specifically caused by Human Papillomavirus (HPV).

10 Feb 2015

New study reveals eight highly specific physical signs associated with death in cancer patients

While the diagnosis of an impending death is always sad, it can be important for patients, families, and clinicians as they make decisions related to hospital discharge, hospice referral, and treatments. Now a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, has revealed eight highly specific physical signs associated with death within three days in cancer patients.

10 Feb 2015

Researchers identify physical, cognitive signs associated with imminent death in patients with cancer

Researchers at The University of Texas MD Anderson Cancer Center have identified eight highly specific physical and cognitive signs associated with imminent death in cancer patients. The findings, published in the journal Cancer, could offer clinicians the ability to better communicate with patients and families.

9 Feb 2015

February is American Heart Month

February is American Heart Month, the perfect time to be reminded to take care of your heart. "Heart disease is the leading cause of death for both men and women," says Gerald Sotsky, M.D., Chair of Cardiac Services, Valley Medical Group.

9 Feb 2015

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.

8 Feb 2015

ACA offers simple walking tips to improve cardiovascular and muscle health

Sedentary lifestyles are the root cause of many obesity-related diseases and neuromuscular conditions. Research shows an inactive lifestyle has a debilitating effect on our cardiovascular and muscle health as we age, therefore exercise is imperative. This is why chiropractic physicians often advise walking more to help relieve low back pain and boost overall wellness.

6 Feb 2015

Study examines use of yoga therapy to address lymphedema

Cancer is bad enough. But cancer patients who receive surgery, radiation and chemotherapy may suffer from side effects that run from irritating to crippling — problems that are postural, musculoskeletal and respiratory, along with lowered self-esteem. Many suffer from lymphedema, swelling caused by retained fluid in a compromised lymphatic system.

6 Feb 2015

Study focuses on two natural approaches to preventing breast cancer

Preventing cancer requires intimate knowledge of how cancer starts, what causes it to grow and flourish, and how to stop it in its tracks. Sometimes this comes in the form of a vaccine (the HPV vaccine for cervical and head and neck cancers), a screening (a colonoscopy for colorectal cancer) or a blood test (the PSA level test for prostate cancer).

5 Feb 2015

Genomics of papillary thyroid carcinoma (PTC): an interview with Professor Thomas J. Giordano

There are two types of thyroid cells and therefore there are two broad types of thyroid cancer. Medullary carcinoma is derived from parafollicular or C cells, whereas follicular cells give rise to several types of thyroid cancers.

4 Feb 2015

Women’s risk factors for heart disease

Heart disease is often thought of as a health problem for men, but more and more women die of heart disease each year than men, and from any other disease including breast cancer.

4 Feb 2015

Researchers offer critical new information about head and neck squamous cell cancer

Head and neck squamous cell cancer (HNSCC) ranks among the top ten most prevalent cancers in the United States. Despite its prevalence, little is known about how this cancer develops and spreads. However, in a paper published in the January 29, 2015 edition of Nature, researchers offer critical new information about head and neck cancers.

4 Feb 2015

Experts recommend sublingual immunotherapy for treatment of allergic rhinitis

Sublingual immunotherapy is one of several state-of-the-science treatments for allergic rhinitis, or "hay fever," being recommended by a panel of experts in a new guideline published Feb. 2, 2015, by the American Academy of Otolaryngology--Head and Neck Surgery Foundation.

3 Feb 2015

UCLA offers new hope to patients suffering from phrenic nerve damage

David Powell could not catch his breath. The 35-year-old from San Diego got winded walking up the stairs, exercising or even just bending over to tie his shoes.

2 Feb 2015

Researchers outline new approach to facelift surgery in patients with massive weight loss

Patients undergoing bariatric surgery for severe obesity are often left with excess, sagging skin affecting all areas of the body--including the face.

2 Feb 2015

Neck News and Research

Survey finds high levels of abuse, serious harm associated with human trafficking

Researchers say that cancer experience can lead to healthy lifestyle in survivors and family members

Cervarix effective against other common cancer-causing HPVs

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Montefiore Einstein Center for Cancer Care receives CoC accreditation

Scientists find that collagen 'cross-links' can determine tumor's ability to grow and spread

New model proposed for predicting outcomes more accurately in HPV-related throat cancer patients

New study reveals eight highly specific physical signs associated with death in cancer patients

Researchers identify physical, cognitive signs associated with imminent death in patients with cancer

February is American Heart Month

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

ACA offers simple walking tips to improve cardiovascular and muscle health

Study examines use of yoga therapy to address lymphedema

Study focuses on two natural approaches to preventing breast cancer

Genomics of papillary thyroid carcinoma (PTC): an interview with Professor Thomas J. Giordano

Women’s risk factors for heart disease

Researchers offer critical new information about head and neck squamous cell cancer

Experts recommend sublingual immunotherapy for treatment of allergic rhinitis

UCLA offers new hope to patients suffering from phrenic nerve damage

Researchers outline new approach to facelift surgery in patients with massive weight loss

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News